PHARMACY

Dr. Reddy’s says diabetes drug meets clinical goals

BY Allison Cerra

HYDERABAD, India An India-based drug maker said its investigational drug for treating diabetes met its goals in a phase 3 trial.

Dr. Reddy’s and Denmark-based Rheoscience said that balaglitazone, a diabetes drug, met its primary endpoint of reduction of blood glucose levels in its study of insulin therapy for a period of 26 weeks.

“These results offer the opportunity for a constructive series of dialogues with both potential partners as well as regulatory agencies. We look forward to working with Rheoscience to define the path forward for balaglitazone,” said GV Prasad, vice chairman and CEO, Dr. Reddy’s.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Walgreens offering H1N1 vaccinations at all pharmacies, Take Care Clinics nationwide

BY Allison Cerra

DEERFIELD, Ill. The once-scarce H1N1 vaccine now is available daily at all of the more than 7,100 Walgreens pharmacies and 350 Take Care Clinics throughout the country, Walgreens announced Monday.

With nearly all states lifting priority group vaccination restrictions, Walgreens is able to offer H1N1 vaccine to anyone in those states who wants a vaccination and who meets state age requirements. Priority group vaccination restrictions are still in effect in Hawaii only.

H1N1 vaccinations are available at Walgreens pharmacies on a walk-in basis when an immunizing pharmacist is on staff and also may be available by appointment. Additionally, Take Care Clinics at select Walgreens stores in 19 states have board-certified nurse practitioners and physician assistants who will provide vaccinations on a walk-in basis daily, pending vaccine availability. Age restrictions for pharmacist-administered vaccinations vary by state, while Take Care Clinics can immunize children ages 2 years and above.

“We share with government and health officials nationwide the goal of protecting as many people as possible from the H1N1 virus, while also helping to lessen the impact or prevent a third wave of H1N1 activity,” said Walgreens president and CEO Greg Wasson. “Soon, anyone in the country who wants an H1N1 vaccination will be able to get one. And by offering convenient, affordable access to the vaccine, as well as other health and wellness resources, Walgreens continues to play an integral role in helping people stay well throughout the flu season.”

The cost for the administration of H1N1 vaccine at Walgreens and Take Care Clinics is $18. Vaccinations are covered by Medicare and may be covered by Medicaid and other insurance plans. Consumers are encouraged to check with their insurance provider for coverage details.

For the nearest Walgreens pharmacy, consumers can call 1-800-Walgreens or visit www.walgreens.com/flu. For Take Care Clinic locations, consumers should visit www.takecarehealth.com or call 1-866-Take-Care.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Teva announces availability of Parkinson’s disease generic

BY Allison Cerra

NORTH WALES, Pa. A generic drug maker has announced the availability of a treatment of the signs and symptoms of idiopathic Parkinson’s disease.

Pramipexole diHCl tablets are available in a 0.125-mg strength, in a bottle size of 63; and in 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths in bottle sizes of 90. The generic is equivalent to Mirapex, which was developed by Boehringer Ingelheim Pharmaceuticals.

“Our customers count on Teva for a continuous supply of new generic products,” said Maureen Cavanaugh, VP customer operations and marketing. “With the launch of pramipexole dihydrochloride tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?